Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
CH. N. Everolimus ***
CH. N. Everolimus ***'s subsections
Company
Mechanism: mTOR Kinase Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2018. 11.20.
TradeMark
TradeMark Web-Site
CH. N. Everolimus ***'s products
This section has no products
Company
Mechanism: mTOR Kinase Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2018. 11.20.
TradeMark
TradeMark Web-Site